Uptake and presentation of hepatitis C virus-like particles by human dendritic cells
/in Chronic Virus Hepatitis, International Publications /von 2005-01-18 / Blood 2005 May;105(9):3605-14Effects of febrile temperature on adenoviral infection and replication: implications for viral therapy of cancer
/in Hyperthermia, International Publications, Newcastle Disease Virus /von 2005-01-01 / J. Virol. 2005 Jan;79(1):581-91Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0
/in Hyperthermia, International Publications, Prostate Cancer /von 2005-01-01 / Strahlenther Onkol 2005 Jan;181(1):35-41Comparison of the anti-tumor effects of various whole-body hyperthermia protocols: correlation with HSP 70 expression and composition of splenic lymphocytes
/in Hyperthermia, International Publications, Malignant Melanoma /von 2005-01-01 / Immunol. Invest. 2005;34(3):245-58Effects of PSK on T and dendritic cells differentiation in gastric or colorectal cancer patients
/in Gastric Cancer, International Publications /von 2005-01-01 / Anticancer Res. 2005 Jan-Feb;25(1B):443-9Toward personalized immunotherapy for non-Hodgkin lymphoma: targeting the idiotypic immunoglobulin
/in International Publications, Malignant Lymphoma /von 2005-01-01 / BioDrugs 2005;19(5):289-97[Combined radiotherapy and endovascular x-ray therapy for invasive cancer of the urinary bladder]
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 2005-01-01 / Vopr Onkol 2005;51(6):685-8Dendritic cells in clinical trials for multiple myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2005-01-01 / Methods Mol. Med. 2005;109:127-36Technology Insight: vaccine therapy for prostate cancer
/in International Publications, Prostate Cancer /von 2005-01-01 / Nat Clin Pract Urol 2005 Jan;2(1):44-51
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution